1. Thyroid eye disease: Redefining its management-A review.
- Author
-
Jain AP, Jaru-Ampornpan P, and Douglas RS
- Subjects
- Diplopia diagnosis, Humans, Quality of Life, Exophthalmos, Graves Ophthalmopathy diagnosis, Graves Ophthalmopathy drug therapy
- Abstract
Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints. Teprotumumab offers an early, safe therapeutic intervention to help reverse disease end points such as diplopia and proptosis and improve quality of life., (© 2021 Royal Australian and New Zealand College of Ophthalmologists.)
- Published
- 2021
- Full Text
- View/download PDF